Exosens | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Exosens

BRIEF

published on 11/20/2025 at 07:35, 14 days 21 hours ago

Exosens Receives MSCI "A" Rating for ESG Policies

Governance Environmental Impact Exosens ESG Practices MSCI Rating
PRESS RELEASE

published on 11/20/2025 at 07:30, 14 days 21 hours ago

Exosens awarded an “A” rating by MSCI for its ESG policies
Exosens awarded an "A" rating by MSCI for its ESG policies, highlighting reliability, security, and positive environmental impact. Recognized for governance, Exosens ranks among benchmark players in Aerospace & Defense

Governance Exosens ESG Rating MSCI Aerospace & Defense
BRIEF

published on 09/29/2025 at 07:35, 2 months 5 days ago

Exosens Secures Key Contract with Spanish Army for Night Vision Monoculars

Military Technology Night Vision NVLS Exosens Contract Spanish Army
PRESS RELEASE

published on 09/29/2025 at 07:30, 2 months 5 days ago

Exosens secures major contract with the Spanish army for 17 000 advanced night vision monoculars
Exosens secures major contract with the Spanish Army for 17,000 advanced night vision monoculars, strengthening its position as a key supplier for Spanish Forces

Exosens Contract Night Vision NVLS Spanish Army
BRIEF

published on 07/30/2025 at 08:50, 4 months 5 days ago

Exosens Releases 2025 Half-Year Financial Report

Innovation Financial Report Electro-optical Technologies Exosens 2025
PRESS RELEASE

published on 07/30/2025 at 08:45, 4 months 5 days ago

Exosens announces the publication of its 2025 half-year financial report
Exosens announces the publication of its 2025 half-year financial report. The report is available on the company's website. Exosens is an innovator in optoelectronics

French Financial Markets Authority Exosens Optoelectronics 2025 Half-year Financial Report Innovator
BRIEF

published on 05/26/2025 at 17:50, 6 months 9 days ago

Exosens Shareholders Approve Key Resolutions at General Meeting

Governance General Meeting Exosens Dividends 2024 Financials
PRESS RELEASE

published on 05/26/2025 at 17:45, 6 months 9 days ago

Exosens: Combined General Meeting of 23 May 2025
Exosens shareholders approve 2024 financial statements and dividend payment at the Combined General Meeting on 23 May 2025 in France

Shareholders Financial Statements Governance Exosens Dividends
BRIEF

published on 04/28/2025 at 07:35, 7 months 6 days ago

Exosens Reports Robust Q1 2025 Revenue Growth Driven by Defense Demand

Revenue Growth Defense Market Image Intensifiers Noxant Acquisition Adjusted Gross Margin
PRESS RELEASE

published on 04/28/2025 at 07:30, 7 months 6 days ago

Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance
Exosens reports strong revenue growth of 21.1% to €104.9m in Q1 2025 in the defense market. Adjusted gross margin up 28.1% to €52.6m, fully on track to 2025 guidance

Revenue Growth Exosens Defense Market 2025 Guidance Adjusted Gross Margin

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 48 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 53 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 23 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 18 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 23 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 32 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 12 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 23 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 38 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 22 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE